معرفی
Dr. Yung-Yao Lin serves as a Senior Lecturer at the Centre for Genomics and Child Health within the Blizard Institute, Faculty of Medicine and Dentistry at Queen Mary University of London. His research focuses on developing human-relevant microphysiological models to elucidate pathological mechanisms of neuromuscular disorders and facilitate therapeutic innovation through stem cell and genome engineering technologies.
His academic background includes a BSc from National Taiwan University and a PhD in Genetics from the University of Cambridge. These foundational experiences established his expertise in genetic mechanisms underlying neuromuscular diseases.
Dr. Lin's primary research investigates neuromuscular disorders and skeletal muscle regeneration mechanisms. He integrates human induced pluripotent stem cells (iPSCs), CRISPR-mediated genome engineering, and bioengineering to create disease models for conditions like Duchenne muscular dystrophy and dystroglycanopathies. His laboratory specializes in generating isogenic patient-derived and CRISPR-corrected iPSC lines for disease modeling, drug testing, and regenerative medicine applications, with recent breakthroughs in hydrogel-based transplantation procedures that improve animal welfare while enabling long-term engraftment.
Analysis of his publication history reveals consistent focus on stem cell-based neuromuscular disease modeling, with increasing emphasis on CRISPR correction techniques, optogenetic approaches, and advanced culture systems like organ-on-a-chip platforms. His work demonstrates progression from elucidating glycosylation pathways in dystroglycanopathies to developing functional therapeutic models.
His scientific recognition includes:
- Fellow of the Higher Education Academy (FHEA)
Dr. Lin actively supervises multiple PhD candidates including Natalia Andrea Moreno Sierra (NC3Rs studentship), Fatma Coban Adanur (Turkish Ministry Scholarship), and Alexandra Broughton (MRC ITTP). He has secured over £2 million in competitive research funding from industry partners, patient charities, and the NC3Rs to advance human-relevant models for disease modeling and regenerative medicine. His former students Amaia Paredes-Redondo and Anna Kowala have contributed significantly to publications in high-impact journals.
At the Blizard Institute, Dr. Lin leads a multidisciplinary research group that combines stem cell biology, genome editing, and bioengineering to develop innovative approaches for understanding neuromuscular pathology and accelerating therapeutic development.
